Protocolo terapéutico de las enfermedades autoinflamatorias

Abstract

The repeated episodes of inflammation that characterize autoinflammatory diseases trigger organ damage and occupational disability. Treatment is aimed at reducing the number and intensity of outbreaks as well as avoiding the development of secondary amyloidosis, which is most associated with inflammasomopathies. The most commonly used therapeutic agents include: NSAIDs, corticosteroids, colchicine, and biologic drugs (mainly anti-IL-1 and TNF inhibitors).